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Abstract 1 
The respiratory central pattern generator must respond to chemosensory cues to maintain 2 
oxygen (O2) and carbon dioxide (CO2) homeostasis in the blood and tissues. To do this, 3 
sensorial cells located in the periphery and central nervous system monitor the arterial 4 
partial pressure of O2 and CO2 and initiate respiratory and autonomic reflex adjustments 5 
in conditions of hypoxia and hypercapnia. In conditions of chronic intermittent hypoxia 6 
(CIH), repeated peripheral chemoreceptor input mediated by the nucleus of the solitary 7 
tract induces plastic changes in respiratory circuits that alter baseline respiratory and 8 
sympathetic motor outputs and result in chemoreflex sensitization, active expiration, and 9 
arterial hypertension. Herein, we explored the hypothesis that the CIH-induced 10 
neuroplasticity primarily consists of increased excitability of pre-inspiratory/inspiratory 11 
neurons in the pre-Bötzinger complex. To evaluate this hypothesis and elucidate neural 12 
mechanisms for the emergence of active expiration and sympathetic overactivity in CIH-13 
treated animals, we extended a previously developed computational model of the 14 
brainstem respiratory-sympathetic network to reproduce experimental data on peripheral 15 
and central chemoreflexes post-CIH. The model incorporated neuronal connections 16 
between the 2nd-order NTS neurons and peripheral chemoreceptors afferents, the 17 
respiratory pattern generator, and sympathetic neurons in the rostral ventrolateral medulla 18 
in order to capture key features of sympathetic and respiratory responses to peripheral 19 
chemoreflex stimulation. Our model identifies the potential neuronal groups recruited 20 
during peripheral chemoreflex stimulation that may be required for the development of 21 
inspiratory, expiratory and sympathetic reflex responses. Moreover, our model predicts 22 
that pre-inspiratory neurons in the pre-Bötzinger complex experience plasticity of 23 
channel expression due to excessive excitation during peripheral chemoreflex. 24 
Simulations also show that, due to positive interactions between pre-inspiratory neurons 25 
in the pre-Bötzinger complex and expiratory neurons in the retrotrapezoid nucleus, 26 
increased excitability of the former may lead to the emergence of the active expiratory 27 
pattern at normal CO2 levels found after CIH exposure. We conclude that neuronal type 28 
specific neuroplasticity in the pre-Bötzinger complex induced by repetitive episodes of 29 
peripheral chemoreceptor activation by hypoxia may contribute to the development of 30 
sympathetic over-activity and hypertension. 31 
  2 
Introduction 32 
Hypertension is a highly prevalent public health problem that affects a large 33 
proportion of population worldwide (Kearney et al., 2005, Carey, 2013, Go et al., 2014). 34 
Accumulating evidence shows that reducing sympathetic nerve activity decreases blood 35 
pressure in hypertensive patients, especially in those who are resistant to pharmacologic 36 
antihypertensive treatment (Esler, 2009, Fisher and Paton, 2012), suggesting that 37 
sympathetic overactivity is a major contributor to the development and maintenance of 38 
hypertension. Moreover, experimental data indicate that increased activity of the 39 
sympathetic nervous system is pivotal for the development of high blood pressure in 40 
rodent models of hypertension (Simms et al., 2009, Malpas, 2010, Briant et al., 2015). 41 
This scenario of hypertension and sympathetic overactivity is observed in obstructive 42 
sleep apnea (OSA) patients (Narkiewicz et al., 1998). OSA is a condition characterized 43 
by recurrent upper airway collapses during sleep and affects approximately 20% of adult 44 
population in USA (Konecny and Somers, 2011). Untreated OSA has cumulative effects 45 
on the cardiovascular system, leading to augmented baseline sympathetic activity and 46 
arterial hypertension that can be refractory to pharmacological therapies (Williams et al., 47 
2010, Pedrosa et al., 2011). Studies estimate that 50–56% of individuals with OSA are 48 
hypertensive (Dudenbostel and Calhoun, 2011).  49 
Clinical and experimental evidence suggests that chronic exposure to intermittent 50 
hypoxia (CIH) is a main factor leading to cardiovascular dysfunction in OSA patients 51 
(Fletcher, 2001, Caples et al., 2005). In rats, CIH promotes hypertension linked to 52 
elevated baseline sympathetic vasomotor tone and higher noradrenaline plasma levels 53 
(Braga et al., 2006, Zoccal et al., 2007, Zoccal et al., 2008, Zoccal et al., 2009) 54 
highlighting a relationship among CIH, sympathetic overactivity and hypertension. 55 
Importantly, the high levels of sympathetic activity of CIH rats were associated with 56 
strengthened coupling between respiratory and sympathetic networks. Indeed, we 57 
originally reported (Zoccal et al., 2008) that CIH exposure promotes an increase in 58 
sympathetic activity during the expiratory phase, specifically during the late part of 59 
expiration (late-E). These additional expiratory bursts in sympathetic activity of CIH rats 60 
were coupled to the late-E bursts emerging in the abdominal expiratory motor output. 61 
Moreover, the late-E activity was present at rest in eucapnia in CIH-treated animals but 62 
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never in untreated controls, and was eliminated by a reduction of CO2 content in the 63 
perfusate (Molkov et al., 2011). The involvement of respiratory-sympathetic interactions 64 
in the development of hypertension in CIH rats is further supported by recent findings 65 
that late-E modulation in the pre-sympathetic neurons of rostral ventrolateral medulla 66 
(RVLM ) depends on synaptic inputs from bulbar respiratory neurons rather than on 67 
changes in their intrinsic properties (Moraes et al., 2013, Moraes et al., 2014). All 68 
together these data indicate that CIH-induced sympathetic overactivity is linked to the 69 
transition of expiration from a passive to an active process at rest. These findings 70 
represent novel and unexplored aspects of central mechanisms underpinning arterial 71 
hypertension in CIH rats (Moraes et al., 2012b).  72 
The development of arterial hypertension in rats exposed to CIH is fully 73 
prevented by previous ablation of carotid body peripheral chemoreceptors (Fletcher et al., 74 
1992), indicating that the plasticity in the neural circuitries of the peripheral chemoreflex, 75 
elicited by repeated stimulation during CIH (Moraes et al., 2015), may underpin the 76 
development of the observed respiratory and sympathetic changes. Therefore, it is 77 
important to understand the neural pathways engaged during peripheral chemoreceptor 78 
stimulation in order to identify potential neural mechanisms triggering active expiration 79 
and sympathetic overactivity in CIH rats. Here, we develop the hypothesis that central 80 
plasticity accounts for the facilitation of sympathetic and respiratory response to 81 
peripheral chemoreflex in CIH conditioned rats. Accordingly, the objectives of this study 82 
were (i) to model the neural pathways required for the adjustments in the respiratory and 83 
sympathetic motor outputs during peripheral chemoreflex activation, (ii) to understand 84 
the functional implications of their repetitive activation during CIH conditioning, and (iii) 85 
to shed light on where within the network the origin of neuronal plasticity occurs that is 86 




 In the present study, we combined recent published studies (Braga et al., 2006, 91 
Zoccal et al., 2008, Molkov et al., 2011, Moraes et al., 2012a, McBryde et al., 2013, 92 
  4 
Moraes et al., 2014) and new experimental data obtained in the in situ arterially perfused 93 
preparation of decerebrate rats, as described in details below. 94 
 95 
Experimental data 96 
 97 
Animals and ethical approval 98 
Experiments were performed on male Holtzman rats, weighing 70-90 g, obtained 99 
from the Animal Care Unit of the São Paulo State University, Araraquara, and kept at 100 
22±1 °C on a 12-h light/dark cycle (lights on 06:00 – lights off 18:00), with access to 101 
food and water ad libitum. All experimental approaches followed the Guide for the Care 102 
and Use of Laboratory Animals published by the US National Institutes of Health (NIH 103 
publication No. 85-23 revised 1996) and by the Brazilian National Council for Animal 104 
Experimentation Control (CONCEA), and was approved by the Local Ethical Committee 105 
in Animal Experimentation (protocol 18/2014). 106 
 107 
Chronic intermittent hypoxia (CIH) 108 
The rats were exposed to CIH as previously described (Zoccal et al., 2008). 109 
Briefly, the animals were housed in collective cages (maximum of 5 animals per cage) 110 
and maintained inside chambers equipped with gas injectors as well as sensors of O2, 111 
CO2, humidity and temperature, at controlled conditions of temperature (22±1°C) and 112 
humidity (55±10%). The CIH protocol consisted of 5 minutes of normoxia (FiO2 of 113 
20.8%) followed by 4 minutes of pure N2 injection into the chamber in order to reduce the 114 
fraction of inspired O2 (FiO2) to 6%, remaining at this level for 40 seconds. After this 115 
hypoxic period, pure O2 was injected to return the FiO2 back to 20.8%. This 9-minute 116 
cycle was repeated 8 hours a day (from 9:30 am to 5:30 pm) for 10 days. During the 117 
remaining 16 hours, the animals were maintained at a FiO2 of 20.8%. The injections of 118 
N2 and O2 (White Martins, São Carlos, Brazil) were regulated by a solenoid valve system 119 
whose opening-closing control was performed by a computerized system (Oxycycler, 120 
Biospherix, USA). In an identical chamber in the same room, the control group was 121 
exposed to a FiO2 of 20.8% 24 hours a day for 10 days. The control rats were also 122 
exposed to a similar valve noise due to the frequent injection of O2 to maintain the FiO2 at 123 
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20.8%. In both CIH and control chambers, the gas injections were performed at the upper 124 
level of the chamber in order to avoid direct jets of gas impacting on the animals, which 125 
could cause stress. 126 
 127 
In situ arterially perfused preparation of decerebrate rats 128 
Arterially perfused in situ preparations (Paton, 1996) of control and CIH rats were 129 
surgically prepared, as previously described (Zoccal et al., 2008). The rats were deeply 130 
anesthetized with halothane (AstraZeneca, Cotia, SP, Brazil) until loss of paw withdrawal 131 
reflex, transected caudal to the diaphragm, submerged in a chilled Ringer solution (in 132 
mM: NaCl, 125; NaHCO3, 24; KCl, 3; CaCl2, 2.5; MgSO4, 1.25; KH2PO4, 1.25; dextrose, 133 
10) and decerebrated at the precollicular level. Lungs were removed. Preparations were 134 
then transferred to a recording chamber, the descending aorta was cannulated and 135 
perfused retrogradely with Ringer solution containing 1.25 % Polyethylene glycol (an 136 
oncotic agent, Sigma, St Louis, USA) and a neuromuscular blocker (vecuronium 137 
bromide, 3-4 μg.mL-1, Cristália Produtos Químicos Farmacêuticos Ltda., São Paulo, 138 
Brazil), using a roller pump (Watson-Marlow 502s, Falmouth, Cornwall, UK) via a 139 
double-lumen cannula. The perfusion pressure was maintained in the range of 50–70 140 
mmHg by adjusting the flow rate to 21- 25 ml.min-1 and by adding vasopressin to the 141 
perfusate (0.6 – 1.2 nM, Sigma, St. Louis, MO, USA). The perfusate was gassed 142 
continuously with 5% CO2-95% O2, warmed to 31–32°C and filtered using a nylon mesh 143 
(pore size: 25 μm, Millipore, Billirica, MA, USA). Sympathetic and respiratory nerves 144 
were isolated and their activity recorded simultaneously using bipolar glass suction 145 
electrodes held in micromanipulators (Narishige, Tokyo, Japan). Left phrenic nerve (PN) 146 
discharges were recorded from its central end and its rhythmic ramping activity was used 147 
to monitor preparation viability. Left cervical vagus (cVN) and hypoglossal nerves (HN) 148 
as well as right thoracic/lumbar abdominal nerves (AbN; T13-L1) were isolated, cut 149 
distally and their central activity recorded. Thoracic sympathetic activity was recorded 150 
from the left sympathetic chain (tSN) at T8–T12 level. All the signals were amplified, 151 
band-pass filtered (0.1–3 kHz; P511, Grass Technologies, Middleton, USA) and acquired 152 
in an A/D converter (CED micro 1401, Cambridge Electronic Design, CED, Cambridge, 153 
UK) to a computer using Spike 2 software (5 KHz, CED, Cambridge, UK). At the end of 154 
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the experiments, the perfusion pump was turned off to determine the electrical noise 155 
(after the death of the preparations). 156 
All analyses were carried out on rectified and integrated signals (time constant of 157 
50 ms) and performed off-line using Spike 2 software (CED, Cambridge, UK) after noise 158 
subtraction. PN burst frequency was determined from the time interval between 159 
consecutive integrated phrenic peak bursts and expressed in bursts per minute (bpm). tSN 160 
activity was measured as the mean values (in μV) of integrated signals. The changes in 161 
the PN burst frequency and tSN in response to peripheral chemoreflex activation were 162 
expressed as percentage values in relation to basal values prior to the stimulus.  163 
 164 
Peripheral chemoreflex activation 165 
Peripheral chemoreceptors were stimulated in the in situ preparations by 166 
injections of potassium cyanide (KCN 0.05%, 50 μl) into the descending aorta via the 167 
perfusion cannula as described previously (Costa-Silva et al., 2010).  Stimulation of the 168 
peripheral chemoreflex receptors by KCN produced consistent autonomic and respiratory 169 
responses, which present low variability within and among the experiments. 170 
 171 
Statistical analyses 172 
The data were expressed as mean ± standard error of mean (SEM). Before 173 
analysis, data distribution was tested using the Shapiro–Wilk normality test. The 174 
sympathoexcitatory and tachypneic responses to peripheral chemoreceptor activation in 175 
control and CIH rats were compared using, unpaired Student’s t-test or two-way ANOVA 176 
for repeated measurements followed by Newman-Keuls post-test, respectively. The 177 
analysis was carried out using GraphPad Prism software (version 5, La Jolla, CA, USA) 178 
and differences were considered significant at P < 0.05. 179 
 180 
Modeling and simulations 181 
 182 
The model presented here is based on a previous model of central chemoreceptor 183 
sensitization from (Molkov et al., 2011, Molkov et al., 2014b), which in turn combined a 184 
model describing the origin of abdominal late-E activity (Molkov et al., 2010) and a 185 
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model describing sympathy-respiratory coupling in the context of the baroreflex (Baekey 186 
et al., 2010). All of these models descend from the model described by Rybak et al. 187 
(2007) and Smith et al. (2007), which explain the change in respiratory patterns due to 188 
successive pontine and medullary transections performed in rats. Most neuronal 189 
populations were composed of single-compartment Hodgkin-Huxley style neuronal 190 
models. Each population contained 20 or 50 neurons. Neurons in postsynaptic 191 
populations each received input from every neuron in the presynaptic population or the 192 
appropriate drive element. The output of certain populations, including motoneurons, was 193 
obtained by integrating excitatory synaptic input. Heterogeneity of model parameters and 194 
initial conditions (such as membrane potential, calcium concentration, and gating 195 
variables) were set by random distributions. Parameters for synaptic weights including 196 
changes relative to Molkov et al. (2011) can be found in Table 1. 197 
Simulations were performed using the NSM simulation package version 3.0 198 
developed at Drexel University by S. Markin, I. Rybak, and N. Shevtsova and ported for 199 
parallel computing on high-performance clusters using OpenMPI by Y. Molkov. 200 
Numerical solutions to ordinary differential equations were computed using the 201 
exponential Euler method for integration with a step of 0.1 ms. 202 
 203 
Results 204 
Peripheral chemoreflex, respiratory and sympathetic adjustments and 205 
exposure to chronic intermittent hypoxia: experimental evidence 206 
Effects of CIH on CO2 threshold for apnea and active expiration in rats in situ 207 
 We previously demonstrated (Molkov et al., 2011) that rats exposed to chronic 208 
intermittent hypoxia exhibit changes in excitability within the respiratory network. This 209 
was verified by the evaluation of the respiratory responses to varying levels of CO2. 210 
Figure 1 shows the AbN and PN motor patterns in in situ preparations of control rats 211 
(upper traces) and in rats after CIH conditioning (lower traces) at different CO2 contents 212 
in the perfusate: normocapnia (5% CO2, middle traces); hypercapnia (7% and 10% CO2, 213 
right traces) and hypocapnia (1% and 3% CO2, left traces). As it is evident from the 214 
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figure, in normocapnia control rats exhibited a passive expiratory pattern, as only PN 215 
activity showed rhythmic discharges of inspiratory activity, and AbN remained fairly 216 
quiescent. With progressive increase in CO2 large amplitude discharges appeared in the 217 
AbN activity of control rats at the late-E phase of the respiratory cycle signifying a 218 
transition to active expiration. In CIH-conditioned rats, AbN late-E discharges were 219 
present during normocapnia. Lowering CO2 content to 3% abolished these discharges. 220 
So, the CO2 threshold for transition to active expiration was between 5% and 7% for 221 
naïve animals, and between 3% and 5% for the CIH conditioned rats. 222 
 As CO2 level decreased from 3% to 1% the PN rhythmic activity ceased in naïve 223 
animals but not in rats exposed to CIH (see first column in Fig. 1, which depicts 224 
representative traces from one control rat and one CIH conditioned rat). These results 225 
imply that the CO2 apneic threshold was between 1% and 3% CO2 in the control group, 226 
and below 1% in the CIH animals. Accordingly, both thresholds for apnea and for the 227 
transition to active expiration are approximately 2% CO2, lower in CIH conditioned 228 
animals as compared to naïve rats. All data quantification and analyses are presented in 229 
details in(Molkov et al., 2011).  230 
 231 
Respiratory and sympathetic adjustments elicited by peripheral chemoreflex activation 232 
 Previous studies have demonstrated the changes in the pattern of PN, tSN 233 
and AbN activities in response peripheral chemoreflex activation (Dick et al., 234 
2004, Moraes et al., 2012a). Herein, we extended this characterization and also 235 
evaluated the changes in cVN and HN activities. Transient stimulation of CB 236 
peripheral chemoreceptors of control in situ preparations with KCN (n=7) had a profound 237 
effect on activity patterns in all motor outputs that lasted 10-15s (see Fig. 2 for typical 238 
responses). There was an approximately two-fold increase in respiratory frequency (∆PN 239 
frequency: 114±18%, from 22±6 to 46±6 bpm, P<0.05; Fig. 2C) accompanied by 240 
augmented post-inspiratory amplitude recorded from the cVN (∆cVN: 68±5%, P<0.05, 241 
Fig. 2C) and an abrupt rather than decrementing ending as seen during baseline activity. 242 
Abdominal, hypoglossal and sympathetic nerve activities also increased mainly during 243 
the post-I period (∆AbN: 105±34 %, ∆HN: 149±25 %, ∆tSN: 94±5 %, P<0.05, Fig. 2C). 244 
Importantly, at the end of the stimulus these strong post-I discharges disappeared from all 245 
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nerves simultaneously suggesting that they may had a common origin. In addition, the 246 
AbN and HN exhibited late-E discharges during stimulation that strongly resembles 247 
hypercapnia-evoked late-E activity. Similar late-E related discharges were also seen in 248 
the sympathetic outflow. 249 
 It was previously suggested that the source of late-E AbN activity activated by 250 
hypercapnia was in the RTN/pFRG (Janczewski and Feldman, 2006, Abdala et al., 2009, 251 
Molkov et al., 2010). To understand if the AbN modulation induced by peripheral 252 
chemoreflex originates from the same location, Moraes et al. (2012a) suppressed the 253 
RTN activity by muscimol (GABAA receptor agonist) before stimulating peripheral 254 
chemoreceptors by KCN. Interestingly, late-E discharges disappeared from both 255 
abdominal and sympathetic nerves without affecting the post-I responses. This 256 
observation suggests that post-I and late-E activities in AbN and tSN during peripheral 257 
chemoreflex have different origins. Late-E activity most probably has the same source as 258 
observed during hypercapnia originating from the RTN, whereas the source of post-I 259 
activity is located elsewhere. 260 
 261 
Exaggerated respiratory and sympathetic chemoreflex responses after CIH exposure 262 
Typical recordings of PN,  tSN, AbN and cVN activities of control and CIH rats, 263 
illustrating the pattern of changes in response to peripheral chemoreflex activation, are 264 
shown in Fig. 3A and B. Consistent with previous observations (Braga et al., 2006), we 265 
verified that in situ preparations of CIH rats (n=8) exhibited amplified 266 
sympathoexcitatory responses to peripheral chemoreflex stimulation (128±8 vs 94±5%, P 267 
< 0.05, Fig. 3C) in comparison to the control group (n=7). The enhanced sympathetic 268 
chemoreflex response in CIH rats also showed augmented respiratory modulation, with 269 
bursts occurring preferentially during the post-inspiratory phase. In relation to the PN 270 
frequency, the analysis of percentage changes respective to basal values indicated that 271 
CIH and control groups presented a similar increase in the magnitude of PN frequency 272 
(80±21 vs 114±18%, 2s after stimulation, respectively). However, the PN frequency 273 
remained elevated at 4 (144±36 vs 77±12%, P < 0.01) and 6s (151±36 vs 66±13%, P < 274 
0.001) after the stimulation of peripheral chemoreceptors in CIH rats, indicating 275 
prolongation of tachypnea (Fig. 3D). With respect to AbN chemoreflex response, the 276 
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magnitude of increase was similar in both groups (104±21 vs 105±34%, Fig. 3E). 277 
However, a different pattern of AbN response is observed in CIH in relation to control 278 
rats. In control rats, the relative increase in AbN expiratory activity occurs during the 279 
post-inspiration (55±2% of the response) and late expiration (45±2% of the response), 280 
with prevalence in the former (P<0.05, Fig. 3F). In the CIH group, however, the evoked 281 
AbN response is shifted towards the late expiratory phase (late expiration: 65±2% vs 282 
post-inspiration: 35±2%, P < 0.001, Fig. 3F),. The magnitude of increase in cVN in 283 
response to KCN was similar between CIH and control groups (75±8 vs 68±5 %, 284 
respectively, Fig. 3G). Together, these data supports the notion that the processing of 285 
sympathetic, inspiratory and late-expiratory responses to peripheral chemoreflex is 286 
facilitated in rats exposed to CIH. 287 
 288 
Pre-I/I neurons in spontaneously hypertensive rats  289 
 In a different animal model of neurogenic hypertension, the spontaneously 290 
hypertensive rat (SHR), Moraes et al. (2014) demonstrated that intrinsically bursting 291 
neurons in the pre-BötC were found to have altered electrophysiological properties. 292 
Specifically, the authors showed that pre-BötC pre-inspiratory neurons are more excitable 293 
due to significantly lower conductance of the leak current. Interestingly, SHR and CIH 294 
rat models of hypertension share many common features: 1) strengthened respiratory-295 
sympathetic coupling are suggested to be involved in the development/maintenance of 296 
arterial hypertension (Zoccal et al., 2008, Moraes et al., 2014); 2) the carotid body 297 
chemoreceptors play a pivotal role for the development of hypertension (Fletcher et al., 298 
1992, Abdala et al., 2012); 3) the sympathetic response to peripheral chemoreceptors are 299 
amplified in SHR and CIH rats (Braga et al., 2006, Simms et al., 2009, Tan et al., 2010, 300 
Moraes et al., 2014), suggesting a sensitization of processing of peripheral chemoreceptor 301 
inputs; 4) presence of a late-expiratory component in the AbN, in the cervical 302 
sympathetic and in the pre-sympathetic RVLM neuronal activity at normal (5%) CO2 303 
levels strongly resembling the respiratory pattern of control (Wistar) animals at 7% CO2 304 
(Zoccal et al., 2008, Moraes et al., 2013, Moraes et al., 2014); and 5) a lower apneic 305 
threshold compared to Wistar rats (Moraes et al., 2014) (Molkov et al., 2011). Based on 306 
these similarities, we hypothesize that CIH-conditioned animals have altered baseline 307 
  11 
respiratory patterns due to increased excitability of pre-I/I population in pre-BötC 308 
because of the reduced leak conductance of these neurons (Moraes et al., 2014, 2015). 309 
We tested this hypothesis using computational modeling.  310 
 311 
Effects of peripheral chemoreceptor activation on the brainstem respiratory and 312 
sympathetic networks: insights from computational modeling  313 
 314 
Model description 315 
 The main objective of the modeling part of our study was to provide mechanistic 316 
interpretation of the processes involved in peripheral chemoreflex modulation of the 317 
respiratory and pre-sympathetic networks. This included: (1) an increase in respiratory 318 
frequency; (2) the appearance of post-I activity in the HN, AbN, and tSN and an 319 
augmentation of post-I activity amplitude in the cVN; (3) the appearance of late-E 320 
activity in the HN, AbN, and tSN; and (4) an increase in respiratory-independent activity 321 
of tSN.  322 
  The model included a population of 2nd-order cells in the NTS receiving 323 
peripheral chemoreceptor inputs and their efferent projection to ventromedullary 324 
compartments. The schematic of the extended model is shown in Fig. 4.  325 
  We extended the model to include new neuronal populations that mediate the 326 
peripheral chemoreflex. During peripheral chemoreflex, input from the carotid body (CB) 327 
was represented by a constant drive to the 2nd-order NTS neurons. This population of 328 
simple spiking neurons distributed excitatory projections to the respiratory and 329 
sympathetic circuits. To account for the increase in respiratory frequency, which should 330 
primarily occur through shortening of the E2 phase, we implemented direct excitation 331 
from the 2nd-order NTS neurons to the early-I (1) and pre-I/I populations of the pre-BötC. 332 
The pre-I/I population is the primary excitatory population contributing to the initiation 333 
of inspiration.  334 
To account for the post-I activity in motoneuron output, we introduced another 335 
post-I population (bulbo-spinal cVRG). This population receives tonic excitation from 336 
the 2nd-order NTS neurons during peripheral chemoreflex. In addition, the activity of this 337 
population is modulated by the respiratory CPG; inhibition from aug-E and early-I (2) 338 
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shape its output to allow only post-I activity. This population receives tonic excitation 339 
from 2nd-order chemoreceptive neurons in the NTS. Activation of this population during 340 
inspiration is prevented by inhibition from early-I (2); activation of this population during 341 
E2 is suppressed by inhibition from aug-E. Thus, activation of and excitation from the 342 
2nd-order chemoreceptive NTS neurons translate to post-I activity in the cVRG. This 343 
post-I (cVRG) population is responsible for post-I activity in the HN, AbN, and tSN and 344 
augments the post-I component in the cVN. 345 
 In our previous model, we described how CO2-sensitive drive from the RTN 346 
mediated the central chemoreflex in respiratory circuits (Molkov et al., 2010, Molkov et 347 
al., 2011). Increased drive from the RTN could drive the pFRG late-E population to 348 
threshold, and in this way, the central chemoreflex induces  the onset of bursting activity 349 
in the pFRG, which is observed as late-E activity in the AbN. In the extended model, a 350 
CO2-sensitive drive excites two distinct neuronal populations in the RTN (RTN-late-E 351 
and RTN-cpg) (see Fig. 4). One of these populations—the RTN-cpg—also received input 352 
from 2nd-order NTS chemoreceptive neurons. The dynamics of individual neurons in 353 
these two RTN populations were not modeled; rather, we directly simulated the firing 354 
rate of the population. The RTN-cpg population projected to: pre-I/I (pre-BötC), early-I 355 
(1) (pre-BötC), post-I (BötC), and late-E (pFRG). The RTN-late-E population projected 356 
only to the late-E population of the pFRG. Therefore, the pFRG late-E population 357 
receives excitatory projections from both peripheral chemoreflex sensitive and peripheral 358 
chemoreflex insensitive central chemoreceptive populations in the RTN. The CO2-359 
dependence of RTN-cpg and RTN-late-E is the same and mediates the central 360 
chemoreflex in a similar fashion to the direct CO2-sensitive drive in Molkov et al. (2011). 361 
Progressive hypercapnia and hypocapnia were modeled by changing the magnitude of the 362 
CO2 sensitive drive to RTN-cpg and RTN-late-E. 363 
Since stimulation of the peripheral chemoreceptors can initiate late-E activity in 364 
the AbN, which is RTN-dependent (Moraes et al., 2012a), we extended the model to 365 
include excitation from 2nd-order NTS peripheral chemoreceptive neurons to augment 366 
excitatory drive from the RTN to the CPG. We implemented a direct projection from the 367 
2nd-order NTS chemoreceptive neurons to the RTN-cpg population. The RTN-cpg 368 
population distributes both central and peripheral chemosensory drive to the respiratory 369 
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circuits. Notice that the RTN-late-E population does not receive excitation from the 2nd-370 
order NTS chemoreceptive neurons, so this component of excitatory input to the pFRG 371 
late-E population is dependent on the central chemoreflex but independent of the 372 
peripheral chemoreflex.  373 
 The model by Baekey et al. (2010) described the baroreflex circuits, including 374 
2nd-order baroreceptive NTS neurons and the pre-sympathetic circuits in the ventrolateral 375 
medulla. In that model, 2nd-order baroreceptive NTS neurons directly excited the CVLM, 376 
which inhibited RVLM to provide sympathoinhibition. Here, we implement a parallel 377 
pathway where 2nd-order peripheral chemoreceptive NTS neurons project directly to the 378 
RVLM in order to mediate sympathoexcitation during peripheral chemoreflex for which 379 
there is experimental evidence (Aicher et al., 1996, Koshiya and Guyenet, 1996). 380 
 As mentioned above, hypercapnia induces late-E activity in the AbN. CIH rats 381 
experience a hypocapnic shift in the threshold for emergence of this late-E activity 382 
(Abdala et al., 2009, Molkov et al., 2010, Molkov et al., 2011) (Fig. 1). On the other 383 
hand, experimental evidence in SHR suggests that the pre-I/I population in the pre-BötC 384 
becomes more excitable via a decrease in leak conductance (Moraes et al., 2014). We 385 
used this evidence to formulate the hypothesis that repetitive activation of peripheral and, 386 
hence, central chemoreceptors during CIH (see emphasized excitatory projections in Fig. 387 
4) conditioning induces plasticity in this population as recently proposed (Moraes et al., 388 
2015, Zoccal, 2015); specifically, we modelled the respiratory plasticity evoked by CIH 389 
as a decrease in the leak conductance of the pre-I/I population. The average leak 390 
conductance of these neurons was decreased from 2.9 nS in the control model to 2.3 nS in 391 
the CIH model. In order for the increase in excitability of the pre-I/I population to 392 
contribute to the excitability of the late-E (pFRG) population, we implemented a direct 393 
excitatory projection from pre-I/I (pre-BötC) to late-E (pFRG). The relative increase of 394 
the sympathoexcitatory response to peripheral chemoreceptor activation was 395 
implemented by a change in the chemosensory drive to 2nd-order peripheral 396 
chemoreceptive NTS neurons (see Table 1). 397 
 398 
Simulation of peripheral chemoreceptor activation in naïve rats 399 
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The extended model was used to investigate the effects of peripheral 400 
chemoreceptors activation on the respiratory-sympathetic networks. Fig. 5A and Fig. 6A 401 
depict the activity of the respiratory circuits during normal conditions and during 402 
activation of peripheral chemoreceptors. A square pulse of excitatory drive to the 2nd-403 
order NTS chemoreceptive neurons elicited an increase in network frequency which was 404 
based on the additional excitation to pre-I/I and early-I (1) neurons  that overcame 405 
inhibition from the inhibitory populations in the BötC and initiate inspiration. Hence, the 406 
expiratory phase decreased in duration. Specifically, the duration of bursts in the aug-E 407 
and post-I populations of the BötC decreased (Fig. 6A). However, the duration of 408 
inspiration (Fig. 5A) and the burst duration of early-I (1) (Fig. 6A) did not change 409 
substantially. After peripheral chemoreceptor stimulation, the model captured the 410 
appearance of post-I activity in the HN, AbN, and tSN and increased post-I activity in the 411 
cVN that are prevalent in experimental recordings (Fig. 7). In the model, this activity was 412 
driven by the post-I (cVRG) population; it was silent without input from 2nd-order NTS 413 
chemoreceptive neurons, and received respiratory modulation in the form of inhibition 414 
from BötC aug-E and strong inhibition from pre-BötC early-I (1) (see Fig. 4). This 415 
inhibition occurred in the I-phase and E2-phase of respiration (Fig. 6A).  416 
We propose that 2nd-order NTS chemoreceptive neurons project directly to central 417 
chemosensory populations of the RTN. During peripheral chemoreceptor activation, the 418 
CO2 sensitive drive from RTN-cpg to the respiratory circuits is augmented. Hence, the 419 
pathway for stimulation of the late-E (pFRG) population becomes active (Fig. 6A). The 420 
model captured the appearance of late-E activity in the HN, AbN, and tSN that is 421 
prevalent in experimental recordings. The increase in drive to the pFRG was sufficient to 422 
induce periodic bursts of activity immediately preceding each inspiratory burst (Fig. 7). 423 
Tonic and respiratory-modulated activity in tSN during peripheral chemoreceptor 424 
activation increased due to converging direct and indirect excitatory pathways to RVLM. 425 
RVLM possessed a strong post-I component due to excitation from the post-I population 426 
in cVRG and a late-E component originating from the pFRG (Fig. 7). 427 
 428 
Simulation of transient activation of peripheral chemoreceptors in naïve rats with RTN 429 
suppressed 430 
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 Evidence suggests that late-E activity in the AbN during hypercapnia is dependent 431 
on an excitatory drive from the RTN (Molkov et al., 2010, Moraes et al., 2012a). 432 
Moreover, late-E activity in the AbN is abolished upon suppression of the RTN (Moraes 433 
et al., 2012a). Here, we reproduce experimental results of RTN suppression in the model. 434 
Fig. 5B and Fig. 6B depict activation of peripheral chemoreceptors with the RTN 435 
suppressed. To simulate the effects of muscimol injected in the RTN, we inhibited the 436 
central chemosensory populations in the RTN and the late-E pacemaker in pFRG. This 437 
manipulation was mimicked by reducing the CO2 sensitive drive to RTN-cpg and RTN-438 
late-E from 1.08 nS to 0.84 nS. Input from 2nd-order NTS peripheral chemoreceptive 439 
neurons to the central chemosensory complex in the RTN was not able to overcome 440 
inhibition by muscimol and activate the late-E population. The activation of the post-I 441 
population in the cVRG and the projections from the 2nd-order NTS chemoreceptive 442 
neurons into the respiratory CPG and pre-sympathetic groups was unaffected by 443 
suppression of the RTN (Fig. 5B and Fig. 6B). Due to the inhibition of the RTN, the late-444 
E population in the pFRG remained silent during peripheral chemoreceptor activation 445 
(Fig. 6B), and hence, no late-E activity appeared in the AbN and tSN motor outputs (Fig. 446 
5B). Decrease in drive to the RTN also reduces drive distributed to the CPG; RTN 447 
suppression induces a reduction in the baseline frequency of the respiratory rhythm. 448 
 449 
Simulation of transient activation of peripheral chemoreceptors in CIH rats 450 
 The main difference in the effect of peripheral chemoreceptors in CIH compared 451 
to naïve rats is a substantial increase in sympatho-excitation (Braga et al., 2006) (Fig. 3). 452 
The tonic component of sympatho-excitation is mediated by a direct projection from 2nd-453 
order NTS chemoreceptive neurons to the pre-sympathetic RVLM. Activation of this 454 
chemosensory drive leads to a tonic component to the sympathetic outflow during 455 
peripheral chemoreceptor activation by means of this direct projection to RVLM (Fig. 456 
8A).  To accommodate an increase in sympatho-excitation in CIH compared to the 457 
control model, we increased the amplitude of the peripheral chemoreceptor input by a 458 
factor of approximately 2. During peripheral chemoreceptor activation, the firing 459 
frequency of 2nd-order NTS chemoreceptive neurons is greater in the CIH model than in 460 
the control model. As such, the efficacy of the excitatory projection to RVLM is greater, 461 
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which causes greater sympathetic outflow in the CIH model upon activation of the 462 
peripheral chemoreceptors (Fig. 8B). These effects of increased chemosensory drive in 463 
the CIH model are only visible during activation of the peripheral chemoreceptors. 464 
sensors. 465 
 466 
Simulation of progressive hypercapnia and hypocapnia in the naïve model and the 467 
CIH model 468 
 A hallmark of CIH in the respiratory circuits is a hypocapnic shift in the threshold 469 
for the emergence of self-sustained rhythmic respiratory activity (apneic threshold) and a 470 
hypocapnic shift in the threshold for the emergence of active expiration. Previously, we 471 
described these changes in terms of direct sensitization of the RTN to the partial pressure 472 
of CO2 in the blood (Molkov et al., 2011, Rybak et al., 2012, Molkov et al., 2014b). The 473 
previous model does not describe the mechanism by which CIH induces plasticity in the 474 
respiratory CPG. As described above, the pre-I/I population in the pre-BötC of SHR has 475 
smaller leak conductance compared to Wistar rats (Moraes et al., 2014). Here, we extend 476 
the model to incorporate similar change in the pre-I/I population to explain CIH induced 477 
plasticity to the respiratory CPG. Increased excitability of pre-I/I population readily 478 
explains a lower apneic threshold after CIH. By adding a glutamatergic excitatory 479 
projection from this pre-I/I population to the late-E population in the pFRG, the increased 480 
excitability in the pre-BötC is integrated by the pFRG to lower its threshold for 481 
activation. This projection mediates a change in the active expiration threshold induced 482 
by plasticity to the pre-I/I population in the CIH model. 483 
 In the model, we incrementally increased central chemosensory drive in the 484 
control and CIH models to simulate progressive increase in blood CO2 from normocapnia 485 
at 5% to mild and then strong hypercapnia at respectively 7% and 10% partial pressure of 486 
CO2 (Fig. 9A). To accommodate progressive hypercapnia in the model, we changed the 487 
weight of the CO2 sensitive drive to RTN-cpg and RTN-late-E to 1.2 nS for 7% CO2 and 488 
to 1.32 nS for 10% CO2. This simulation is parallel to experiments performed in the 489 
arterially perfused preparation where the partial pressure of CO2 in the perfusate was 490 
implemented over the same incremental range (Molkov et al., 2011) (Fig. 1). In the 491 
control model, active expiration (marked by the presence of late-E activity in the AbN) 492 
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emerges at 7% CO2 (Fig. 9A). The frequency of these late-E AbN bursts increased in a 493 
quantal fashion (Molkov et al., 2010, Rubin et al., 2011) from 1:2 AbN bursts per 494 
inspiratory PN bursts at 7% CO2 to 1:1 AbN bursts per inspiratory PN bursts at 10% CO2. 495 
In the CIH model, the threshold for emergence of late-E AbN activity is decreased (Fig. 496 
9A) as in normocapnia (5% partial pressure of CO2), AbN bursts are already present after 497 
CIH conditioning.  498 
 We incrementally decreased central chemosensory drive in the control and CIH 499 
models to simulate a progressive decrease in blood CO2 partial pressure from 500 
normocapnia at 5% blood CO2 to mild and then strong hypocapnia - 3% and 1% partial 501 
pressure of CO2 respectively. We accomplished progressive hypocapnia in the model by 502 
decreasing the weight of the CO2 sensitive drive to RTN-cpg and RTN-late-E to 0.72 nS 503 
for 3% CO2 and to 0 nS for 1% CO2. In the control model, respiratory activity—504 
represented as inspiratory bursts reflected in the PN—persists in mild hypocapnia (Fig. 505 
9B, Control, 3% CO2) but disappears in strong hypocapnia (Fig. 9B, Control, 1% CO2). 506 
After CIH a decrease from 5% to 3% CO2 eliminates late-E discharges in AbN (Fig. 9B, 507 
After CIH). A further decrease to 1% CO2 does not stop the respiratory rhythm as 508 




The model presented qualitatively reproduced the effects of peripheral 513 
chemoreflex activation in the arterially perfused preparation of decerebrate rats. By 514 
changing a subset of biophysical parameters, the model was also able to reproduce the 515 
response to progressive hypercapnia and hypocapnia as well as increased 516 
sympathoexcitation in CIH. This model provided possible mechanistic explanations to 517 
the peripheral chemoreflex response and to plasticity induced by CIH. The model was 518 
based on several hypotheses that can be tested in experimental animals (each developed 519 
further below): (Hypothesis 1) 2nd-order peripheral chemoreceptive neurons in the NTS 520 
project directly to the RTN central chemoreceptors (the anatomical projections were 521 
previously confirmed by Takakura et al. (2006)); (Hypothesis 2) sympathetic neurons in 522 
the RVLM receive convergent excitatory inputs from late-E (pFRG), a post-I population 523 
  18 
in the cVRG, and 2nd-order chemoreceptive neurons in the NTS; and (Hypothesis 3) CIH-524 
induced plasticity in the brainstem circuits can be explained be a down-regulation of 525 
ohmic leak channels in the pre-I/I population (pre-BötC). 526 
 527 
Peripheral chemoreflex in control rats 528 
 529 
 During peripheral chemoreceptor stimulation the respiratory frequency 530 
substantially increases (Fig. 2) whereas RTN central chemoreceptor activation during 531 
hypercapnia does not lead to significant frequency variations (Molkov et al., 2010, 532 
Molkov et al., 2014a). Based on this we assumed that NTS peripheral chemoreceptors 533 
accelerate phrenic discharges by exciting the inspiratory neurons in the pre-BotC which 534 
was reflected in the model by direct excitatory projections from NTS to the pre-I/I 535 
population (Fig. 4). This possibility is supported by previous studies showing that 536 
microinjections of glutamate in the pre-BötC increase PN frequency in vivo and in situ 537 
while the antagonism of ionotropic glutamatergic receptors in this area eliminated the 538 
PN, but not the AbN and tSN responses to peripheral chemoreflex activation in situ 539 
(Moraes et al., 2011, Moraes et al., 2012c). 540 
 Peripheral chemoreceptor activation led to the emergence of late-E discharges in 541 
the abdominal and sympathetic nerve activities (Fig. 2). These late-E bursts strongly 542 
resembled the discharges appearing in the same nerves during hypercapnia (Molkov et 543 
al., 2011). Appearance of late-E activity during hypercapnia is mediated by the increased 544 
tonic drive provided by the RTN chemoreceptors (Molkov et al., 2010). Further, late-E 545 
discharges emerging in AbN and tSN during peripheral chemoreceptor stimulation can be 546 
abolished by pharmacological suppression of the RTN (Moraes et al., 2012a). These facts 547 
are consistent with the hypothesis that NTS second order peripheral chemoreceptive 548 
neurons send excitatory inputs to the RTN central chemoreceptors (Takakura et al., 2006) 549 
(Hypothesis 1). This was implemented in the model as direct excitatory projections from 550 
2nd order peripheral chemoreceptive NTS neurons to RTN chemoreceptors (Fig. 4). 551 
 Activation of peripheral chemoreceptors was accompanied by powerful 552 
discharges in HN, cVN, AbN, and tSN motor outputs during the post-inspiratory phase of 553 
the respiratory cycle (Fig. 2). This means that activation of 2nd order NTS 554 
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chemoreceptive cells may have a direct excitatory effect on expiratory neurons. Direct 555 
excitation of post-I or aug-E neurons in the BötC compartment of the respiratory CPG 556 
would be inconsistent with an increase in the respiratory frequency. Accordingly, we 557 
suggest that this post-I activity is recruited at the level of pattern formation rather than 558 
pattern generation. In the model, we placed a new population in the cVRG which is silent 559 
at baseline conditions.  560 
 There is well-documented evidence of direct excitatory projections from 2nd order 561 
NTS peripheral chemoreceptive neurons to the RVLM (see Accorsi-Mendonca and 562 
Machado (2013) for review) which mediate sympathoexcitatory effect of peripheral 563 
chemoreceptor stimulation. Our model implies that there are at least two more indirect 564 
pathways mediated by the respiratory neurons (Hypothesis 2).  565 
 The first is a consequence of excitatory projections from RTN late-E population 566 
to RVLM suggested in our previous publications (Baekey et al., 2010, Molkov et al., 567 
2011, Rybak et al., 2012, Molkov et al., 2014b) to explain appearance of late-E 568 
discharges in the sympathetic activity during hypercapnia. The RTN late-E population 569 
receives excitatory drive from the RTN central chemoreceptors which increases with 570 
blood CO2 level due to their intrinsic CO2 chemosensitivity. Our model suggests that an 571 
excitatory input from the NTS peripheral chemoreceptors to RTN central chemoreceptors 572 
(Takakura et al., 2006), is functionally important to activate RTN late-E neurons and to 573 
consequently evoke late-E discharges in the sympathetic nerve during peripheral 574 
chemoreceptor stimulation. The critical role of the RTN in the generation of late-E bursts 575 
during peripheral chemoreflex was previously demonstrated (Moraes et al., 2012a). 576 
 The second indirect pathway is mediated by the post-I population, which we 577 
introduced to explain the occurrence of strong post-inspiratory discharges in multiple 578 
respiratory and sympathetic motor outputs, and putatively placed to the cVRG 579 
compartment of the respiratory network. This new population receives inhibition during 580 
inspiratory and E2 phases, and can only activate during post-inspiration by an excitatory 581 
peripheral chemoreceptor drive from NTS. Apparently, this post-I mediated pathway 582 
seems to play a dominant role, since the depression of post-I activity elicited either by the 583 
glutamatergic antagonism in the NTS (Costa-Silva et al., 2010) or pontine-medullary 584 
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transection (Baekey et al., 2008) significantly attenuated the sympatho-excitatory 585 
response to peripheral chemoreflex stimulation. 586 
 587 
CIH-induced central and peripheral plasticity  588 
 589 
 Given that the pre-I/I population of the pre-BötC is a primary target for tonic 590 
excitatory drives to the respiratory CPG and that these drives are strongly activated 591 
during the peripheral chemoreflex response (Moraes et al., 2014), we speculated that 592 
repetitive activation of the peripheral chemoreflex may induce plasticity of channel 593 
expression due to prolonged excessive excitation. Recent evidence in SHR indicates a 594 
decrease in the leak conductance of pre-inspiratory neurons in the pre-Bötzinger complex 595 
(Moraes et al., 2014) which elevates their excitability.  Our model shows that similar 596 
changes as a result of CIH exposure may explain abovementioned downshifts in the CO2 597 
thresholds (Hypothesis 3). However, the mechanisms responsible for such plasticity 598 
remains to be found.  599 
One possibility is that this change is mediated by downregulation of potassium 600 
leak channels. Persistent and repetitive activation of group I metabotrobic glutamate 601 
receptors over the course of CIH conditioning would increase the catalyzation of 602 
diacylglycerol, leading to activation of protein kinase C and the subsequent decrease of 603 
the leak conductance through channel protein trafficking (Gabriel et al., 2012). Another 604 
example of similar changes consistent with the timescale considered in our study is an 605 
excitotoxicity-mediated transcriptional decrease in HCN channel function found to 606 
increase excitability of CA1 cells (Adams et al., 2009). In that study an induced increase 607 
in synchronous burst duration correlated with a reduction in HCN2 mRNA levels which 608 
persisted for at least 7 days. HCN channels are primarily permeable to K+ ions, and, 609 
hence, their downregulation positively affects the excitability. This is consistent with the 610 
recent idea of peripheral chemoreceptor mediated channelopathy within the respiratory 611 
network in SHRs (Moraes et al., 2015). 612 
 As already mentioned, after CIH conditioning the respiratory CPG exhibits higher 613 
respiratory rate and lower CO2 thresholds for both late-E activity emergence and 614 
hypocapnic apnea (Figs. 1, 9). Previously this was explained by increased CO2 sensitivity 615 
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of the RTN central chemoreceptors following CIH exposure (Molkov et al., 2011) but no 616 
experimental evidence of any intrinsic changes in the central chemoreceptors is available. 617 
Our present model provides a different explanation based on increased excitability of the 618 
pre-BötC pre-I/I population discussed above. Since this population is a main driver of the 619 
inspiratory activity in the network, its increased excitability alone would lead to a lesser 620 
dependence on excitatory drive from RTN central chemoreceptors and, hence, to a lower 621 
apneic threshold. To explain the lower threshold for late-E emergence, we hypothesize 622 
and implement in the model that pre-I/I neurons send excitatory projections to the RTN 623 
late-E population (Fig. 4). Due to increased excitability after CIH exposure, pre-I/I 624 
neurons increase their firing including the pre-I (late-E) phase and thus provide additional 625 
excitation to the RTN late-E population which underlies the emergence of late-E activity 626 
at lower CO2 levels (Fig. 9). 627 
 CIH conditioned rats exhibit a stronger peripheral chemoreflex evoked 628 
sympathetic response than control animals (Fig. 3). We speculated that this effect reflects 629 
stronger activation of the direct sympathoexcitatory pathway rather than indirect inputs 630 
from respiratory populations. This assumption is in accord with the fact that CIH 631 
exposure increases the duration but not the magnitude of the respiratory response to 632 
peripheral chemoreceptor stimulation (Fig. 3). We suggest that the underlying mechanism 633 
is chronic sensitization of peripheral chemoreceptors during CIH conditioning which 634 
finds strong experimental support (Abdala et al2012; Pawar et al., 2008, Tan et al., 2010, 635 
Zoccal et al., 2011, Costa-Silva et al., 2012, Kumar and Prabhakar, 2012). That is not to 636 
say that baseline facilitation of motoneuron activity in CIH rats is dependent on 637 
peripheral chemoreceptor sensitization. For example, AbN and tSN late-E activity 638 
persists despite carotid body transection after CIH conditioning (Zoccal et al., 2008). 639 
Alternative brainstem plasticity could contribute to increased peripheral 640 
chemoreflex sympathoexcitation after CIH conditioning. For example glutamatergic 641 
transmission in the NTS is augmented in CIH (Costa-Silva et al., 2012). In this case, 642 
plasticity of NTS chemoreceptive neural response to peripheral chemoreflex stimulation 643 
could amplify the motoneuron responses independent of the strength of the input from the 644 
carotid body. Besides, CIH conditioning increases the strength of the purinergic 645 
sympathoexcitatory response in the RVLM (Zoccal et al., 2011). This mechanism could 646 
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account for increased sympathoexcitatory response to peripheral chemoreflex 647 
stimulation. In the model we implement that as a greater activity of the 2nd-order 648 
chemoreceptive NTS neurons in CIH-conditioned animals as compared to the naïve ones. 649 
Our simulations support the plausibility of this assumption (Fig. 8). 650 
 651 
Summary and Conclusions 652 
 653 
The generation of novel bursts in sympathetic activity coupled with the 654 
emergence of active expiration has been highlighted as an important mechanism 655 
underpinning high levels of sympathetic activity and arterial pressure in rats submitted to 656 
CIH (Zoccal et al., 2008, Zoccal et al., 2009, Moraes et al., 2013). Although carotid body 657 
chemoreceptors were found to be critical for the development of CIH-induced arterial 658 
hypertension (Fletcher et al., 1992), inputs from peripheral chemoreceptors are not 659 
required for the maintenance of expiratory component of the sympathetic activity – since 660 
the carotid body removal after CIH exposure did not eliminate late-E activity in the 661 
sympathetic nerve (Molkov et al., 2011). In fact, hypocapnia-induced reduction of 662 
respiratory drive canceled the sympathetic and abdominal late-E bursts in CIH rats and 663 
rescued the normal sympathetic burst pattern (Molkov et al., 2011), indicating that 664 
coupling between respiratory and sympathetic networks is a critical mechanisms for 665 
maintenance of sympathetic overactivity after CIH exposure. In our study, we sought to 666 
identify the potential neural mechanisms required for the development of active 667 
expiration and sympathetic overactivity in CIH rats.  668 
In order to simulate motoneuron activity of rats conditioned by CIH, a subset of 669 
parameters in the CIH model were altered from the values in the control model. These 670 
changes reflected central and peripheral plasticity. We modeled central plasticity in the 671 
brainstem by increasing the excitability of the pre-I/I population. The conductance of the 672 
leak current in neurons of the pre-I/I population was changed from 2.9 nS to 2.3 nS. This 673 
change mediated the hypocapnic shift in apneic threshold and the threshold for the 674 
emergence of active expiration (Fig. 9). We mimicked peripheral plasticity due to CIH by 675 
increasing the excitatory drive to 2nd-order chemoreceptive neurons in the NTS during 676 
peripheral chemoreflex. In the control model, the weight of this drive was 0.75 nS, and it 677 
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increased in magnitude to 1.6 nS in the CIH model. The effect of this change is only 678 
visible during stimulation of the peripheral chemoreflex (Fig. 8). 679 
Our hypothesis implies that the discussed plastic changes in the respiratory 680 
network critically depend on the peripheral chemoreceptor input and not on hypoxia per 681 
se. This is indirectly supported by multiple experimental studies (see (Paton et al., 2013a) 682 
for review) and emphasizes the importance of carotid bodies as a possible therapeutic 683 




This study was supported by NIH grant #R01 AT008632 to YIM, APL and DZ. IAR is 688 
funded by NIH grant #R01 NS069220. DZ is funded by São Paulo State Foundation 689 
(FAPESP, grant # 2013/17251-6). JFRP is funded by the British Heart Foundation.  APL 690 
is funded by the International Rett Syndrome Foundation. This work utilized the 691 
computational resources of the NIH HPC Biowulf cluster. (http://hpc.nih.gov). 692 
 693 
Figure legends 694 
 695 
Figure 1. Recordings depict activity of PN and AbN under progressive hypocapnia and 696 
hypercapnia in in situ preparations of control and CIH rats. The hypercapnic threshold for 697 
emergence of late-expiratory activity in AbN decreases after CIH. The hypocapnic 698 
threshold for the appearance of respiratory activity in PN is also decreased in CIH rats. 699 
Adapted from (Molkov et al., 2011). 700 
 701 
Figure 2. Appearance of additional motoneuron activation during peripheral 702 
chemoreceptor activation. Tracings from two recordings from in situ preparations (panels 703 
A and B), representative from the group, showing the changes in the HN, cVN, PN, AbN 704 
and tSN in response to peripheral chemoreceptor activation by KCN (arrows, 0.05%). 705 
Note that during chemoreflex activation, post inspiratory activity increases in cVN and 706 
novel post-inspiratory components appears in tSN, AbN, and HN. Late expiratory activity 707 
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also appears in SN, AbN, and HN. Gray bars highlight post-inspiratory phases of the 708 
respiratory cycle. C. Percent changes in amplitude of different motor outputs during 709 
peripheral chemoreflex activation. 710 
 711 
Figure 3. CIH exaggerates respiratory and sympathetic chemoreflex responses. A. 712 
Tracings from control (left) and CIH (right) rats, representative from their respective 713 
experimental group, showing the PN and tSN responses to stimulation of the peripheral 714 
chemoreflex with KCN (arrows). Note the amplified tSN response during peripheral 715 
chemoreceptor stimulation in CIH rats. B. Tracings from control (left) and CIH (right) 716 
rats, representative from their respective experimental group, showing the PN and AbN 717 
responses to stimulation of the peripheral chemoreflex with KCN (arrows). Note the 718 
prolonged AbN response during peripheral chemoreceptor stimulation in CIH rats. C. 719 
Percent change in tSN amplitude during peripheral chemoreflex in control and CIH rats. 720 
* denotes statistically significant difference. See text for details. D. Time course of the 721 
percent change in respiratory frequency relative to baseline after peripheral 722 
chemoreceptor activation with KCN for control (open squares) and CIH (filled squares) 723 
groups. Data are shown as mean±SD. Note prolonged frequency response in CIH group. 724 
E. No significant difference in percent change in AbN amplitude during peripheral 725 
chemoreflex between control and CIH groups. F. Durations of post-I and late-E 726 
expiratory phases relative to the expiration duration in control and CIH groups during 727 
peripheral chemoreflex. G. No significant difference in percent change in cVN amplitude 728 
during peripheral chemoreflex between control and CIH groups. 729 
 730 
Figure 4. Network connectivity diagram for model of brainstem respiratory circuits. 731 
Brainstem compartments: VRC, ventral respiratory column; BötC, Bötzinger complex; 732 
pre-Bötzinger complex; rVRG, rostral ventral respiratory group; cVRG, caudal ventral 733 
respiratory group; NTS, nucleus tractus solitarii; RTN/pFRG retrotrapezoid 734 
nucleus/parafacial respiratory group; RVLM, rostral ventrolateral medulla; CVLM, 735 
caudal ventrolateral medulla. Neural populations: pre-I/I, pre-inspiratory/inspiratory; 736 
early-I(1), early inspiratory (1); ramp-I, ramp inspiratory; early-I(2), early inspiratory (2); 737 
post-I, post inspiratory; post-I (e), post inspiratory excitatory; aug-E, augmenting 738 
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expiratory; 2nd Chemo, 2nd-order chemoreceptors; bulbo-spinal post-I, bulbo-spinal post 739 
inspiratory; late-E, late expiratory; IE, inspiratory-expiratory phase-spanning; RTN-CPG, 740 
CO2-sensitive population projecting to CPG and late-E (pFRG); RTN-late-E, CO2-741 
sensitive population projecting just to late-E (pFRG). Motoneurones: PN, phrenic nerve; 742 
AbN, abdominal nerve; tSN, thoracic sympathetic nerve; HN, hypoglossal nerve; cVN, 743 
cervical vagus nerve. Excitatory neural populations, inhibitory neural populations, and 744 
excitatory drives are respectively represented as orange spheres, blue spheres, and green 745 
triangles. Motoneurones are depicted as brown spheres. Red projections originating in 746 
neural populations depict excitatory projections. Blue projections originating in neural 747 
populations depict inhibitory projections. Green projections indicate the distribution of 748 
excitatory tonic drive. The bold excitatory pathways emphasize converging peripheral 749 
chemosensitive projections to the pre-I/I population. Populations that were not included 750 
in a previous model are marked with an asterisk.  751 
 752 
Figure 5. Simulation depicting the response of motoneuron output (HN, cVN, PN, AbN, 753 
and tSN) to the activation of the peripheral chemoreflex (A) and the motoneuron 754 
response during suppression of RTN (B). (A) During activation of peripheral 755 
chemoreflex, network frequency increases; post-inspiratory activity appears in HN, AbN, 756 
and tSN motor nerves, and post-inspiratory activity in cVN increases in amplitude. Late 757 
expiratory activity appears in HN, AbN, and tSN. (B) The suppression of the RTN 758 
abolishes late-expiratory activity in HN, AbN, and tSN but has little effect on post-I 759 
activity. The interval highlighted in yellow corresponds to the duration over which the 760 
peripheral chemoreflex is stimulated. Baseline activity of PN is highlighted in grey to 761 
emphasize the difference in frequency in the control model and the model with RTN 762 
suppressed before the peripheral chemoreflex stimulation. 763 
 764 
Figure 6. Simulation of activity of respiratory and sympathetic populations (early-I (1) 765 
(pre-BötC), post-I (BötC), aug-E (BötC), late-E (pFRG), and post-I (cVRG)) before and 766 
during stimulation of peripheral chemoreflex (A) and the activity of respiratory and 767 
sympathetic populations under suppression of RTN during stimulation of peripheral 768 
chemoreflex (B). (A) Peripheral chemoreflex increases drive to the respiratory central 769 
  26 
pattern generator—increases network frequency and activating the late-E (pFRG) and 770 
post-I(cVRG) populations. (B) The suppression of RTN for the duration of the simulation 771 
abolishes expiratory activity in the late-E (pFRG) population. 772 
 773 
Figure 7. Blow-up of activity during peripheral chemoreflex in the control model. 774 
Motoneuron output is compared to the activity of late-E (pFRG) and post-I (cVRG). 775 
Activity during late-E and post-I phases are highlighted in yellow and grey, respectively. 776 
 777 
Figure 8. Simulations of (A) the control model and (B) the CIH model depicting activity 778 
in PN and tSN. The amplitude of tSN activity is increased in the CIH model compared to 779 
the control model with late-E bursting present. 780 
 781 
Figure 9. Simulations of progressive (A) hypercapnia and (B) hypocapnia in PN and 782 
AbN in the control model and the CIH model. (A) Simulations reproduce hypocapnic 783 
shift in threshold for the emergence of late-expiratory activity in the AbN in the CIH 784 
model. (B) Simulations reproduce hypocapnic shift in the onset of respiratory activity of 785 
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